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Health care is a perennial topic on the public agenda. About 40million
Americans are uninsured, despite a decade of rapid economic growth.
Medical expenditure growth has accelerated in recent years, followed
by double-digit annual increases in commercial health insurance pre-
miums. Meanwhile, public health remains an important challenge; peo-
ple continue to drink and smoke, harming their own health and driving
up costs for others. There is no shortageof health issues for govern-
ments to worry about.
Six years ago, the NBER launched an annual meeting and publication
designed to expose the policy community to research on these policy
issues. Frontiers in Health Policy Research is the result. The goalof the
Frontiers volumes is to foster a dialogue between NBER researchers
and the policy community. NBER researchers write papers on the eco-
nomics of health policy, and these papers are discussed at a joint meet-
ing of researchers and health care analysts. The papers in thisbook
were presented at a conference in Washington,D.C., in May 2002.
As in the past, the chapters in this volume address a diverse setof
topics of great current interest. Despite the apparent dissimilarityin
subject matter, every chapter examines either a cause of cost growth
or the effects of policies intended either to slow or torespond to cost
growth.
In recent years, expenditures for pharmaceuticals have risen faster
than for every other category of medical expenditures, rising 17.3 per-
cent in 2000 alone. At the same time, direct-to-consumer advertising
(DTCA) has become pervasive. Growth in DTCA was coincident with
the FDA's easing of advertising regulations in 1997. According to the
Henry J. Kaiser Family Foundation, DTCA expenditures more than tri-
pled between 1996 and 2000. The growth in DTCA represents a break
from tradition for pharmaceutical companies, which historically hadxiv Introduction
advertised primarily to doctors and other health professionals, not di-
rectly to patients. The new prominence of DTCA is controversial in
part because of fears that uninformed consumers might be easilyma-
nipulated, but also because increased prescription druguse could in-
crease health expenditures. The drugs that are advertised are usually
monopoly products, and much of the cost is reimbursed by insurance.
Thus, demand is often inelastic, and expenditures can bevery high.
Despite ongoing public debate, little is known about theconse-
quences of DTCA for the health care system. What effects does DTCA
have on expenditures for the drug that is the principal object of the
advertising? Do the advertisements promote the use of the individual
drug, thereby increasing its share of the market,or do they mainly
promote the entire class so that the main effect on expenditures for the
drug in question is to share in the rise in sales for the entire drug class?
Meredith B. Rosenthal and her colleagues answer these questions in
the chapter entitled, "Demand Effects of Recent Changes in Prescrip-
tion Drug Promotion." In this chapter the authors discuss what is
known about the effects of DTCA and the ambiguities in the literature
on this topic.
Rosenthal and her coauthors have assembled a unique data set from
the late 1990s on DTCA matched with pharmaceutical sales for several
drugs in six therapeutic classes. They use these data to examine the
effect of advertising on class-level sales and sales of particular drugs
within classes. They find that advertising substantially boosts sales of
that therapeutic class. In classes of drugs thatare advertised most
heavily, pharmaceutical use increases the most. The link between ad-
vertising and sales of particular drugs within a class, however, is
weaker. Rosenthal and her coauthors find inconsistent estimates of the
drug-specific advertising effect. The coefficients vary across specifica-
tions and are not always statistically significant. They conclude that
much of the impact of advertising might be of the "general foot-traffic"
type, rather than the product-specific type. Advertising gets people to
the doctor to talk about a particular medical problem but does notnec-
essarily lead to the purchase of that prescription medication.
Rosenthal et al. estimate that between 9 and 22 percent of the recent
growth in prescription drug spending is attributable to the effects of
direct-to-consumer advertising. Although this figure indicates that ad-
vertising has a large effect, most of the growth in spendingon medica-
tions reflects other phenomena, like the introduction ofmore expensive
drugs or broader drug utilization generally.It may seem self-evident that increases in medical care costs would
lead to lower rates of coverage, but empirical evidence on this point
has been mixed. Researchers have found it difficult to explore the rela-
tionship between cost growth and coverage rates because few data-
bases contain both cost and coverage information. In his paper,
"Employee Costs and the Decline in Health Insurance Coverage," Da-
vid M. Cutler examines whether costs influence coverage. Cutler uses
data from the Current Population Survey over the 1990s and the Kaiser
Family Foundation! Health Education and Research Trust in 1999 to
examine how coverage rates change in response to cost changes.
Cutler first shows that the decline in insurance coverage in the 1990s
is largely a result of fewer people taking up coverage when it is offered,
rather than fewer people being offered insurance. The share of workers
offered health insurance was relatively constant over the 1990s, while
take-up rates fell by several percentage points.
Cutler then relates the take-up rate to the employee cost for insur-
ance. Using firm data in 1999, he shows that the rate of take-up is
strongly related to the part of the premium borne by employees. When
employee costs increase, take-up rates decline. The elasticity of take-
up with respect to employee costs is relatively small. But the increase
in employee costs over the 1990s was relatively large. As a result, Cut-
ler finds that the bulk of the lower take-up rates over the 1990s can be
explained by the increase in employee costs. This finding provides a
warning that recent increases in medical care costs could lead to addi-
tional declines in insurance coverage if they translate into greater em-
ployee payments for insurance.
Insurance take-up is also the subject of Sherry Glied's paper, "Health
Insurance Expansions and the Content of Coverage: Is Something Bet-
ter Than Nothing?" Glied examines ways that health insurance policies
could be designed to produce the greatest value for the currently unin-
sured. Most research focuses only on the price of insurance to the unin-
sured, building on the assumption that lower prices will result in
higher take-up rates. But this conventional belief ignores the possibility
that value, not price, determines take-up; value depends on both price
and the content of coverage. Lower price leads to increased coverage
if the content of the benefits package is held constant, but the benefits
package is not necessarily valuable if its characteristics are also
changing.
In her empirical work, Glied examines what features of insurance
are most likely to maximize enrollment by the uninsured. She con-
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cludes that the uninsured are likely to prefer front-end coverage with
a low benefit maximum to catastrophic coverage, for two reasons. The
first is that many of the uninsured are young and relatively healthy and
so do not value catastrophic coverage highly. Second, the uninsured
already have access to some catastrophic care through emergency
rooms and other settingsthat is, opportunities already exist to "free
ride" for emergency services, while it is difficult or impossible to re-
ceive many of the lower-cost services, like physician office visits, with-
out paying. Thus, the uninsured are less willing to pay for catastrophic
coverage. Glied's findings have important implications for the design
of public insurance expansions.
The economy at large influences the price of care, the content of in-
surance, and insurance coveragecoverage rates rise in good times
and fall when the economy declines. The magnitude of this link is im-
portant in determining how much insurance coverage fluctuates with
the economy, a topic that John Cawley and Kosali I. Simon examine in
their chapter, "The Impact of Macroeconomic Conditions on the Health
Insurance Coverage of Americans." They find that coverage declines
substantially in response to increases in the state unemployment rate,
but that the effects of national recession on coverage are small. In two-
earner families, if the husband or wife loses health insurance, perhaps
due to unemployment, the spouse can obtain insurance, lowering the
risk that they will both lose coverage.
Although health policy discussions often emphasize the importance
of health insurance, policy can influence health in many other ways.
For example, behavior can be the target of policy, and behavioral
choices have a large impact on health. Adverse behaviors are common
and often occur together. Smokers are more likely to drink than are
nonsmokers, and drinkers are more likely to smoke than are nondrink-
ers. Other behaviors might be substitutes. It is widely believed, and
some empirical data suggest, that quitting smoking leads to weight
gain. For public policy analysis, it is important to understand if the
links among different behaviors reflect an underlying structure of com-
plementarity and substitution, or whether they merely reflect individ-
ual heterogeneity. If quitting smoking is more likely to lead to alcohol
reduction, for example, that result would increase the value of smoking
cessation efforts. The opposite would be true if former smokers gained
weight.
Gabriel Picone and Frank Sloan examine the complementarity and
substitution of three behavioral factorssmoking, drinking, andIntroduction xvii
weightin their chapter, "Smoking Cessation and Lifestyle Changes."
They use data from the first five waves (1992-2000) of the Health and
Retirement Study (HRS) to examine the interrelationship among smok-
ing cessation, changes in alcohol consumption, and changes in weight.
Because their data are longitudinal, they can examine changes over
time in these behaviors, and their techniques adjust for sample attrition
over the time period examined
They find that the interrelationships among the adverse health be-
haviors are complex and may differ between genders. Smoking cessa-
tion is negatively correlated with alcohol consumption and, as several
studies have reported, positively correlated with weight gain. Thus, as
the authors note, smoking cessation may create positive externalities
by reducing alcohol consumption; the increase in weight isrelatively
small and is distributed primarily among smokers who are not obese.
The topics addressed by these studies are likely to remain relevant
for many years. Although the studies do not lead directly to policy
recommendations, they add to our understanding of the consequences
of various policy options.